Podcasts about frcsc

  • 74PODCASTS
  • 159EPISODES
  • 39mAVG DURATION
  • 1EPISODE EVERY OTHER WEEK
  • Jun 3, 2025LATEST

POPULARITY

20172018201920202021202220232024


Best podcasts about frcsc

Latest podcast episodes about frcsc

Fertility in Focus by Fertility Matters Canada
Transforming the Fertility Landscape with AI

Fertility in Focus by Fertility Matters Canada

Play Episode Listen Later Jun 3, 2025 42:13


Send us a textThis week Fertility in Focus is thrilled to welcome Jullin Fjeldstad from Future Fertility and Dr. Sony Sierra from Evolve Egg Freezing Clinic, who sat down with us to discuss how they're bringing their unique expertise to the forefront of reproductive technology. These esteemed guests illuminate how AI is reshaping fertility preservation, specifically through the lens of egg freezing. Dr. Sierra provides a compelling overview of how egg freezing empowers individuals to align their reproductive plans with personal and professional aspirations, amidst a growing trend on social media. As more people turn to fertility preservation, understanding its benefits and implications becomes paramount. With insights from both of our guests this week, we explore how AI not only improves clinical outcomes but also offers patients unprecedented control and understanding over their fertility journeys.More about our guest speakers: Jullin Fjeldstad is the Head of Clinical Embryology and Scientific Operations at Future Fertility. Throughout her career, she has always held a passion for innovative ART technologies aimed at improving the fertility journey and IVF outcomes. In her current multi-faceted role, Jullin draws upon her experience as a seasoned embryologist and former lab director to navigate partnering clinics through seamless adoption of Future Fertility's AI-powered oocyte quality assessment tools, as well as overseeing Future Fertility's scientific project collaborations. With her extensive IVF experience and comprehensive understanding of the laboratory operations, she also provides invaluable input to the company's product development processes. Jullin holds a BSc. in Biology from the University of Victoria, Canada and a MSc. in Clinical Embryology from the University of Leeds, UK, where she achieved distinction in both areas.  Dr. Sony Sierra, MD, FRCSC, REI (She/Her), serves as a distinguished Reproductive Endocrinology & Infertility Specialist (REI) and Deputy Medical Director and Partner at TRIO. With nearly two decades of experience, she specializes in reproductive health, recurrent pregnancy loss, and early Recurrent Pregnancy Loss (RPL) programs. As the Medical Director at EVOLVE Egg Freezing Clinic and an Associate Physician at Women's College Hospital, she contributes significantly to advancing reproductive medicine. Dr. Sierra's research interests include infertility, implantation failure, and PCOS, reflected in her publications and conference presentations. Passionate about patient care, she approaches her practice with compassion and dedication, guided by her belief in excellence and empathy. Dr. Sierra's commitment to ongoing education and involvement in esteemed societies ensures her patients receive the most up-to-date care and expertise. She finds immense fulfillment in helping individuals and couples achieve their dreams of starting a family, making her a valued asset in the field of fertility medicine.For more info about Dr. Sierra, you can check out the TRIO Fertility Website: https://triofertility.com/team-member/sony-sierra/ or you can follow her on Instagram @drsonysierra. https://futurefertility.com/https://instagram.com/futurefertilityaihttps://www.youtube.com/@futurefertilityIf you or your organization would like to sponsor educational episodes just like this, please contact us at podcast@fertilitymatters.ca. Follow Fertility Matters Canada at @fertility_canada on Instagram and TikTok.

Advances in Women's Health
Addressing Myths and Missteps in Uterine Fibroid Care

Advances in Women's Health

Play Episode Listen Later May 30, 2025


Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP Despite longstanding reliance on surgery, recent advancements have reshaped our approach to uterine fibroids. However, common myths and misconceptions have limited the adoption of newer therapies, leaving many patients unaware of their available options. Join Dr. Charles Turck and Dr. Ayman Al-Hendy as they explain shifting treatment paradigms and patient education strategies in uterine fibroid care. Dr. Al-Hendy is a Professor of Obstetrics and Gynecology and the Director of Translational Research at the University of Chicago Pritzker School of Medicine.

PeerVoice Oncology & Haematology Video
Shannon Salvador, MD, MSc, FRCSC - Advancing Frontline Endometrial Cancer Care: Translating the Latest Advances in Immunotherapy Plus Chemotherapy Regimens to Practice

PeerVoice Oncology & Haematology Video

Play Episode Listen Later May 30, 2025 25:58


Shannon Salvador, MD, MSc, FRCSC - Advancing Frontline Endometrial Cancer Care: Translating the Latest Advances in Immunotherapy Plus Chemotherapy Regimens to Practice

PeerVoice Endocrinology & Metabolic Disorders Video
Denise Black, MD, FRCSC / Marla Shapiro, C.M., MDCM, CCFP, MHSc, FRCPC, FCFP, MSCP - Navigating the Menopause Transition With Your Patients: Experts Answer Key Questions

PeerVoice Endocrinology & Metabolic Disorders Video

Play Episode Listen Later Apr 8, 2025 12:42


Denise Black, MD, FRCSC / Marla Shapiro, C.M., MDCM, CCFP, MHSc, FRCPC, FCFP, MSCP - Navigating the Menopause Transition With Your Patients: Experts Answer Key Questions

PeerVoice Clinical Pharmacology Video
Denise Black, MD, FRCSC / Marla Shapiro, C.M., MDCM, CCFP, MHSc, FRCPC, FCFP, MSCP - Navigating the Menopause Transition With Your Patients: Experts Answer Key Questions

PeerVoice Clinical Pharmacology Video

Play Episode Listen Later Apr 8, 2025 12:42


Denise Black, MD, FRCSC / Marla Shapiro, C.M., MDCM, CCFP, MHSc, FRCPC, FCFP, MSCP - Navigating the Menopause Transition With Your Patients: Experts Answer Key Questions

PeerVoice Oncology & Haematology Video
Alon Altman, MD, FRCSC, CCPE - It Takes Two: Integrating Immunotherapy in Combination With Chemotherapy Into Recurrent or Primary Advanced Endometrial Cancer Care

PeerVoice Oncology & Haematology Video

Play Episode Listen Later Apr 2, 2025 9:28


Alon Altman, MD, FRCSC, CCPE - It Takes Two: Integrating Immunotherapy in Combination With Chemotherapy Into Recurrent or Primary Advanced Endometrial Cancer Care

Fertility in Focus by Fertility Matters Canada
The Truth About Endometriosis & Fertility with Dr. Sony Sierra

Fertility in Focus by Fertility Matters Canada

Play Episode Listen Later Mar 4, 2025 31:57


Send us a textIn honour of Endometriosis Awareness Month, tune in to this republished, intriguing episode with Dr. Sony Sierra, a renowned reproductive endocrinologist at TRIO Fertility in Toronto and a past president of the Canadian Fertility and Endocrinology Society. Dr. Sierra takes us deep into endometriosis, shedding light on this misunderstood condition.Dr. Sony Sierra unpacks the realities of endometriosis—its overlooked symptoms, diagnostic challenges, and misunderstood impact on fertility. She breaks down the three key ways it affects conception, the best treatment options, and what patients need to know at every stage of their journey. This episode is a must-listen for anyone seeking clarity, support, and empowerment in the fight for endometriosis awareness.More About our Guest Speaker:Dr. Sony Sierra, MD, FRCSC, REI (She/Her), serves as a distinguished Reproductive Endocrinology & Infertility Specialist (REI) and Deputy Medical Director and Partner at TRIO. With nearly two decades of experience, she specializes in reproductive health, recurrent pregnancy loss, and early Recurrent Pregnancy Loss (RPL) programs. As the Medical Director at EVOLVE Egg Freezing Clinic and an Associate Physician at Women's College Hospital, she contributes significantly to advancing reproductive medicine. Dr. Sierra's research interests include infertility, implantation failure, and PCOS, reflected in her publications and conference presentations. Passionate about patient care, she approaches her practice with compassion and dedication, guided by her belief in excellence and empathy. Dr. Sierra's commitment to ongoing education and involvement in esteemed societies ensures her patients receive the most up-to-date care and expertise. She finds immense fulfillment in helping individuals and couples achieve their dreams of starting a family, making her a valued asset in the field of fertility medicine.For more info about Dr. Sierra, you can check out the TRIO Fertility Website: https://triofertility.com/team-member/sony-sierra/ or their Instagram at @triofertility. Follow Dr. Sierra directly at @drsonysierra.If you or your organization would like to sponsor educational episodes just like this, please contact us at podcast@fertilitymatters.ca. Follow Fertility Matters Canada at @fertility_canada on Instagram and TikTok.

AUAUniversity
AUA Guidelines: Diagnosis And Treatment Of Idiopathic Overactive Bladder

AUAUniversity

Play Episode Listen Later Feb 12, 2025 42:30


AUA Guidelines: Diagnosis And Treatment Of Idiopathic Overactive Bladder Co-Host: Anne Pelletier Cameron, MD, FRCSC, URPS Segment #1: Is this an update to the prior Guideline? Segment #2: What is new in the Diagnosis, ntitial Assessment and Initial Management of OAB? Segment#3: What does the Guideline say about Oral Medication? Segment #4: What's new in minimally invasive prodcedures Segment #5: UDS and Cystoscopy Segment #6: What is new and exciting on the horizion for OAB Segment #7: Where to start and the most impactpact research in this area The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder Cameron AP, Chung DE, Dielubanza EJ, et al. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. Published online April 23, 2024. doi:10.1097/JU.0000000000003985. https://www.auajournals.org/doi/10.1097/JU.0000000000003985

PeerVoice Oncology & Haematology Video
Linda Lee, MD, FRCPC / Jacob Rullo, MD, PhD, FRCSC - Managing MEK-Inhibitor–Associated Retinopathy in Metastatic Melanoma: An Expert Discussion

PeerVoice Oncology & Haematology Video

Play Episode Listen Later Dec 13, 2024 9:44


Linda Lee, MD, FRCPC / Jacob Rullo, MD, PhD, FRCSC - Managing MEK-Inhibitor–Associated Retinopathy in Metastatic Melanoma: An Expert Discussion

PeerVoice Brain & Behaviour Video
Linda Lee, MD, FRCPC / Jacob Rullo, MD, PhD, FRCSC - Managing MEK-Inhibitor–Associated Retinopathy in Metastatic Melanoma: An Expert Discussion

PeerVoice Brain & Behaviour Video

Play Episode Listen Later Dec 13, 2024 9:44


Linda Lee, MD, FRCPC / Jacob Rullo, MD, PhD, FRCSC - Managing MEK-Inhibitor–Associated Retinopathy in Metastatic Melanoma: An Expert Discussion

PeerVoice Clinical Pharmacology Video
Linda Lee, MD, FRCPC / Jacob Rullo, MD, PhD, FRCSC - Managing MEK-Inhibitor–Associated Retinopathy in Metastatic Melanoma: An Expert Discussion

PeerVoice Clinical Pharmacology Video

Play Episode Listen Later Dec 13, 2024 9:44


Linda Lee, MD, FRCPC / Jacob Rullo, MD, PhD, FRCSC - Managing MEK-Inhibitor–Associated Retinopathy in Metastatic Melanoma: An Expert Discussion

Clinical Lab Chat
HPV Self-Sampling Is Being Put into Practice in Texas

Clinical Lab Chat

Play Episode Listen Later Dec 9, 2024 23:02


In this episode of Clinical Lab Chat, Jeff Andrews, MD, FRCSC, BD's VP of Global Medical Affairs for Diagnostic Solutions, makes a return visit to the studio for a conversation with CLP's director of business intelligence, Chris Wolski, about BD and MD Anderson's collaboration on HPV sample self-collection study.  Among the topics they cover:How self-collection aids in the fight against cervical cancerThe importance of reaching underserved communitiesHow MD Anderson's program is shining a light on the need for sampling options in the U.S. and across the worldThe business benefits self-collection brings to labsThe impact self-collection will have in the near- and long-term

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast
Jessica Donington, MD, Jonathan D. Spicer, MD, PhD, FRCSC - Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast

Play Episode Listen Later Oct 28, 2024 45:06


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Jessica Donington, MD, Jonathan D. Spicer, MD, PhD, FRCSC - Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Oct 28, 2024 45:06


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
Jessica Donington, MD, Jonathan D. Spicer, MD, PhD, FRCSC - Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

Play Episode Listen Later Oct 28, 2024 45:06


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
Jessica Donington, MD, Jonathan D. Spicer, MD, PhD, FRCSC - Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Oct 28, 2024 45:06


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast
Jessica Donington, MD, Jonathan D. Spicer, MD, PhD, FRCSC - Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways

PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast

Play Episode Listen Later Oct 28, 2024 45:06


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

PeerView Clinical Pharmacology CME/CNE/CPE Video
Jessica Donington, MD, Jonathan D. Spicer, MD, PhD, FRCSC - Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways

PeerView Clinical Pharmacology CME/CNE/CPE Video

Play Episode Listen Later Oct 28, 2024 45:06


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

SAGE Otolaryngology
OTO: Improving Operating Room Efficiency in Otolaryngology–Head and Neck Surgery: A Scoping Review

SAGE Otolaryngology

Play Episode Listen Later Oct 8, 2024 25:05


Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by senior author Julie E. Strychowsky MD, MAS, FRCSC, and Associate Editor Michael J. Brenner, MD, to discuss methods for improving the efficiency of ORs for surgeons as outlined in the paper “Improving Operating Room Efficiency in Otolaryngology–Head and Neck Surgery: A Scoping Review” which published in the October 2024 issue of Otolaryngology–Head and Neck Surgery. They discuss the importance of finding ways to save time and cost for operating rooms in order to serve more patients and reduce physician burnout. Click here to read the full article.    

Clinical Lab Chat
Will HPV Self-Collection Help Prevent Cervical Cancer?

Clinical Lab Chat

Play Episode Listen Later Oct 2, 2024 24:09


In this episode of Clinical Lab Chat, Director of Business Intelligence Chris Wolski interviews Jeff Andrews, MD, FRCSC, a board-certified gynecologist and vice president of Global Medical Affairs for Diagnostic Solutions at BD, what HPV sample self-collection means for the diagnosis, prevention, and treatment of HPV and cervical cancer. Among the topics they cover in this wide-ranging interview:How HPV sample self-collection will improve testing and treatment access.The importance of sample integrity.The larger public health implications of making HPV and cervical cancer screening routine and accessible.The findings of a recent UN General Assembly meeting about HPV diagnosis and treatment.What it's going to take to make cervical cancer a thing of the past.

PeerVoice Oncology & Haematology Video
Alon Altman, MD, FRCSC - Upping the Ante in Advanced Endometrial Cancer Care: Optimizing the Use of Immunotherapy to Improve Patient Outcomes

PeerVoice Oncology & Haematology Video

Play Episode Listen Later Sep 23, 2024 15:19


Alon Altman, MD, FRCSC - Upping the Ante in Advanced Endometrial Cancer Care: Optimizing the Use of Immunotherapy to Improve Patient Outcomes

Gynecologic Oncology
Primary Surgery versus Radiotherapy for Inguinal Lymph Nodes in Vulvar Cancer

Gynecologic Oncology

Play Episode Listen Later Sep 2, 2024 31:59


Editor’s choice: Management of inguinal lymph nodes in locally advanced, surgically unresectable, squamous cell carcinoma of the vulva Editorial: Optimizing and harmonizing lymph node dissection and radiotherapy in advanced vulvar cancer Hosted by: Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic Oncology Featuring: Dr Lilian T. Gien, MD, MSc, FRCSC, University of Toronto, Canada Dr Brenna Swift, MD, FRCSC, MSc, MASc, University of Toronto, Canada Dr Scott Glaser, MD, City of Hope, USA

The NASS Podcast
New Guidelines in Spinal Cord Injury

The NASS Podcast

Play Episode Listen Later Jul 25, 2024 29:47


Ask the Experts: New Guidelines in Spinal Cord Injury Brian K. Kwon, MD, PhD, FRCSC; Michael G. Fehlings, MD, PhD, FRCSC; Rajiv Saigal, MD, PhD; Yi Lu, MD, PhD

Menopause Reimagined
Ep #101: UTIs with Dr. James Simon in Perimenopause and Menopause

Menopause Reimagined

Play Episode Listen Later May 24, 2024 51:46


Dr. James A. Simon is a highly accomplished and respected physician dedicated to advancing research and clinical care in women's sexual and reproductive health. This is his second appearance on our Menopause Reimagined Podcast. The link to his first interview can be found below. We posted a short video, and our viewers asked many questions. So Andrea Donsly, nutritionist, menopause researcher, menopause educator, and co-found of Morphus, invited Dr. Simon back to answer all your questions about Urinary Tract Infections.

SurgOnc Today
Nuts and Bolts of Surgical Management of Perihilar Cholangiocarcinoma – Part 1

SurgOnc Today

Play Episode Listen Later Apr 18, 2024 21:55


In this episode of SurgOnc Today ®, Alex Parikh, MD, MPH, FACS, FSSO, from the University of Texas – San Antonio and Julie Hallet, MD, M.Sc., FRCSC, FSSO from the University of Toronto are joined by Monica M. Dua, MD, from Stanford University and Ching-Wei Tzeng, , MD, FACS, FSSO, from the MD Anderson Cancer Center. They will be discussing two important aspects of the surgical management of perihilar cholangiocarcinoma: strategies for pre-operative optimization and biliary drainage, and management of the future liver remnant. This is part one of a two-part series.

The NASS Podcast
The Shifting Demographics of Spinal Cord Injury: Important Implications for Medicine and Society

The NASS Podcast

Play Episode Listen Later Mar 26, 2024 31:10


Authors Michael G. Fehlings, MD, PhD, FRCSC and Karlo M. Pedro, MD discuss the intricacies of their new SpineLine article, "The Shifting Demographics of Spinal Cord Injury: Important Implications for Medicine and Society," with moderator Kaku Barkoh, MD. Fehlings is an orthopedic surgeon and Pedro is a neurosurgeon. Both are at the University of Toronto; Barkoh is an orthopedic surgeon at Orthopaedic Associates, LLP. in Houston, Texas.

SurgOnc Today
Pancreatic Watch: Is Observation of Non-Functional Sporadic Small PNETs Safe?

SurgOnc Today

Play Episode Listen Later Mar 14, 2024 30:30


In this episode of SurgOnc Today®, Julie Hallet, MD, MSc, FRCSC, FSSO, from the University of Toronto and Vice-Chair of the SSO HPB disease site working group is joined by Stefano Partelli, MD, PhD, from Università Vita-Saluta San Raffaele and Els Nieveen van Dijkum, MD, PhD, from Amsterdam UMC. We will delve into the rationale behind the non-operative management of non-functional sporadic pancreatic neuroendocrine tumors (PNETs) as well as the design and results of two prospective studies, ASPEN and PANDORA. Show Notes: PANDORA: https://academic.oup.com/bjs/article/108/8/888/6202974 ASPEN (interim analysis): https://academic.oup.com/bjs/article/109/12/1186/6672718?login=false

The Prostate Health Podcast
99: Key Takeaways: Society of Benign Prostate Disease 2024 Annual Meeting - Kevin C. Zorn, MD, FRCSC, FACS

The Prostate Health Podcast

Play Episode Listen Later Mar 7, 2024 28:00


I was recently honored to be a guest speaker among the innovators, stakeholders, and pioneering minds in managing benign prostate hyperplasia at the annual assembly of the Society of Benign Prostate Disease, held in Dallas this February.  Today, I am delighted to have one of the Society of Benign Prostate Disease board of directors, Dr. Kevin Zorn, joining me to share an insider perspective as we review the key takeaways from the meeting and bring you up to speed on the latest technologies for evaluating and managing BPH. We will also offer a sneak peek into several new advancements coming down the pipeline.  Dr. Kevin Zorn, from the BPH Canada Clinic in Montreal, is a board-certified urologist and former Associate Professor of Urology at the Universities of Montreal and Chicago, sub-specializing in robotic surgery and BPH surgical care. Throughout his career, Dr. Zorn has been committed to research and innovation. He was the first in Canada and Quebec to use many new BPH technologies, including Greenlight XPS, Rezum, ITind, Optilume, and aquablation. Dr. Zorn is a senior author of the BPH guidelines for the Canadian Urological Association, having authored 345 peer-reviewed publications and 12 book chapters on BPH and minimally invasive surgical care. He has lectured, taught, and practiced surgery globally and is intimately involved in developing several new pioneering BPH technologies. Stay tuned for the latest insights and breakthroughs as we unveil the future of BPH management. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: Dr. Zorn shares some highlights from his presentation on the evaluation of BPH in the modern clinic setting How new technology, like mobile apps and point-of-care ultrasound, can improve the diagnosis and treatment times for BPH Explanation of the UroCuff technology Discussion of the latest technology that has been available over the last year for interventional management of BPH The importance of knowing the personal preferences of patients when selecting their treatment options for BPH The benefits of aquablation technology Dr. Zorn discusses the evolution of BPH treatment Why urologists must remain flexible in their approach to BPH care The importance stay up-to-date with the latest BPH technology and guidelines The potential of AI to empower urologists and improve patient care Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. BPH Canada  Society of Benign Prostate Disease

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast
Jessica Donington, MD / Jonathan D. Spicer, MD, PhD, FRCSC - A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast

Play Episode Listen Later Feb 27, 2024 52:29


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/QRX865. CME/MOC/CC/AAPA credit will be available until February 27, 2025.A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJessica Donington, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen; AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Co-Chair/PlannerJonathan D. Spicer, MD, PhD, FRCSC, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Chemocentryx; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Protalix Biotherapeutics; Regeneron; and Xenetic Biosciences.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; CLS Therapeutics; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; and Protalix Biotherapeutics.Faculty/PlannerPatrick M. Forde, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen Inc.; Ascendis Pharma A/S; AstraZeneca; Bristol Myers Squibb; CureVac SE; F-star Therapeutics Inc.; Flame Pharmaceuticals Pvt Ltd; Fosun Pharma USA Inc.; G1 Therapeutics, Inc.; Genelux Corporation; Genentech, Inc.; Gritstone bio, Inc.; iTeos Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals Inc.; Sanofi; Synthekine; Tavotek Biotherapeutics; and Teva Pharmaceuticals USA, Inc.Grant/Research Support from AstraZeneca; BioNTech SE; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Jessica Donington, MD / Jonathan D. Spicer, MD, PhD, FRCSC - A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Feb 27, 2024 52:36


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/QRX865. CME/MOC/CC/AAPA credit will be available until February 27, 2025.A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJessica Donington, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen; AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Co-Chair/PlannerJonathan D. Spicer, MD, PhD, FRCSC, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Chemocentryx; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Protalix Biotherapeutics; Regeneron; and Xenetic Biosciences.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; CLS Therapeutics; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; and Protalix Biotherapeutics.Faculty/PlannerPatrick M. Forde, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen Inc.; Ascendis Pharma A/S; AstraZeneca; Bristol Myers Squibb; CureVac SE; F-star Therapeutics Inc.; Flame Pharmaceuticals Pvt Ltd; Fosun Pharma USA Inc.; G1 Therapeutics, Inc.; Genelux Corporation; Genentech, Inc.; Gritstone bio, Inc.; iTeos Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals Inc.; Sanofi; Synthekine; Tavotek Biotherapeutics; and Teva Pharmaceuticals USA, Inc.Grant/Research Support from AstraZeneca; BioNTech SE; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
Jessica Donington, MD / Jonathan D. Spicer, MD, PhD, FRCSC - A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

Play Episode Listen Later Feb 27, 2024 52:29


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/QRX865. CME/MOC/CC/AAPA credit will be available until February 27, 2025.A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJessica Donington, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen; AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Co-Chair/PlannerJonathan D. Spicer, MD, PhD, FRCSC, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Chemocentryx; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Protalix Biotherapeutics; Regeneron; and Xenetic Biosciences.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; CLS Therapeutics; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; and Protalix Biotherapeutics.Faculty/PlannerPatrick M. Forde, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen Inc.; Ascendis Pharma A/S; AstraZeneca; Bristol Myers Squibb; CureVac SE; F-star Therapeutics Inc.; Flame Pharmaceuticals Pvt Ltd; Fosun Pharma USA Inc.; G1 Therapeutics, Inc.; Genelux Corporation; Genentech, Inc.; Gritstone bio, Inc.; iTeos Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals Inc.; Sanofi; Synthekine; Tavotek Biotherapeutics; and Teva Pharmaceuticals USA, Inc.Grant/Research Support from AstraZeneca; BioNTech SE; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

PeerView Internal Medicine CME/CNE/CPE Video Podcast
Jessica Donington, MD / Jonathan D. Spicer, MD, PhD, FRCSC - A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC

PeerView Internal Medicine CME/CNE/CPE Video Podcast

Play Episode Listen Later Feb 27, 2024 52:29


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/QRX865. CME/MOC/CC/AAPA credit will be available until February 27, 2025.A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJessica Donington, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen; AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Co-Chair/PlannerJonathan D. Spicer, MD, PhD, FRCSC, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Chemocentryx; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Protalix Biotherapeutics; Regeneron; and Xenetic Biosciences.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; CLS Therapeutics; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; and Protalix Biotherapeutics.Faculty/PlannerPatrick M. Forde, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen Inc.; Ascendis Pharma A/S; AstraZeneca; Bristol Myers Squibb; CureVac SE; F-star Therapeutics Inc.; Flame Pharmaceuticals Pvt Ltd; Fosun Pharma USA Inc.; G1 Therapeutics, Inc.; Genelux Corporation; Genentech, Inc.; Gritstone bio, Inc.; iTeos Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals Inc.; Sanofi; Synthekine; Tavotek Biotherapeutics; and Teva Pharmaceuticals USA, Inc.Grant/Research Support from AstraZeneca; BioNTech SE; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

PeerView Internal Medicine CME/CNE/CPE Audio Podcast
Jessica Donington, MD / Jonathan D. Spicer, MD, PhD, FRCSC - A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC

PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Play Episode Listen Later Feb 27, 2024 52:36


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/QRX865. CME/MOC/CC/AAPA credit will be available until February 27, 2025.A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJessica Donington, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen; AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Co-Chair/PlannerJonathan D. Spicer, MD, PhD, FRCSC, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Chemocentryx; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Protalix Biotherapeutics; Regeneron; and Xenetic Biosciences.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; CLS Therapeutics; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; and Protalix Biotherapeutics.Faculty/PlannerPatrick M. Forde, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen Inc.; Ascendis Pharma A/S; AstraZeneca; Bristol Myers Squibb; CureVac SE; F-star Therapeutics Inc.; Flame Pharmaceuticals Pvt Ltd; Fosun Pharma USA Inc.; G1 Therapeutics, Inc.; Genelux Corporation; Genentech, Inc.; Gritstone bio, Inc.; iTeos Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals Inc.; Sanofi; Synthekine; Tavotek Biotherapeutics; and Teva Pharmaceuticals USA, Inc.Grant/Research Support from AstraZeneca; BioNTech SE; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
Jessica Donington, MD / Jonathan D. Spicer, MD, PhD, FRCSC - A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Feb 27, 2024 52:36


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/QRX865. CME/MOC/CC/AAPA credit will be available until February 27, 2025.A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJessica Donington, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen; AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Co-Chair/PlannerJonathan D. Spicer, MD, PhD, FRCSC, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Chemocentryx; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Protalix Biotherapeutics; Regeneron; and Xenetic Biosciences.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; CLS Therapeutics; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; and Protalix Biotherapeutics.Faculty/PlannerPatrick M. Forde, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen Inc.; Ascendis Pharma A/S; AstraZeneca; Bristol Myers Squibb; CureVac SE; F-star Therapeutics Inc.; Flame Pharmaceuticals Pvt Ltd; Fosun Pharma USA Inc.; G1 Therapeutics, Inc.; Genelux Corporation; Genentech, Inc.; Gritstone bio, Inc.; iTeos Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals Inc.; Sanofi; Synthekine; Tavotek Biotherapeutics; and Teva Pharmaceuticals USA, Inc.Grant/Research Support from AstraZeneca; BioNTech SE; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast
Jessica Donington, MD / Jonathan D. Spicer, MD, PhD, FRCSC - A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC

PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast

Play Episode Listen Later Feb 27, 2024 52:36


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/QRX865. CME/MOC/CC/AAPA credit will be available until February 27, 2025.A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJessica Donington, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen; AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Co-Chair/PlannerJonathan D. Spicer, MD, PhD, FRCSC, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Chemocentryx; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Protalix Biotherapeutics; Regeneron; and Xenetic Biosciences.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; CLS Therapeutics; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; and Protalix Biotherapeutics.Faculty/PlannerPatrick M. Forde, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen Inc.; Ascendis Pharma A/S; AstraZeneca; Bristol Myers Squibb; CureVac SE; F-star Therapeutics Inc.; Flame Pharmaceuticals Pvt Ltd; Fosun Pharma USA Inc.; G1 Therapeutics, Inc.; Genelux Corporation; Genentech, Inc.; Gritstone bio, Inc.; iTeos Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals Inc.; Sanofi; Synthekine; Tavotek Biotherapeutics; and Teva Pharmaceuticals USA, Inc.Grant/Research Support from AstraZeneca; BioNTech SE; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

PeerView Clinical Pharmacology CME/CNE/CPE Video
Jessica Donington, MD / Jonathan D. Spicer, MD, PhD, FRCSC - A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC

PeerView Clinical Pharmacology CME/CNE/CPE Video

Play Episode Listen Later Feb 27, 2024 52:29


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/QRX865. CME/MOC/CC/AAPA credit will be available until February 27, 2025.A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJessica Donington, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen; AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Merck & Co., Inc.Co-Chair/PlannerJonathan D. Spicer, MD, PhD, FRCSC, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Chemocentryx; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Protalix Biotherapeutics; Regeneron; and Xenetic Biosciences.Grant/Research Support from AstraZeneca; Bristol Myers Squibb; CLS Therapeutics; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; and Protalix Biotherapeutics.Faculty/PlannerPatrick M. Forde, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen Inc.; Ascendis Pharma A/S; AstraZeneca; Bristol Myers Squibb; CureVac SE; F-star Therapeutics Inc.; Flame Pharmaceuticals Pvt Ltd; Fosun Pharma USA Inc.; G1 Therapeutics, Inc.; Genelux Corporation; Genentech, Inc.; Gritstone bio, Inc.; iTeos Therapeutics; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals Inc.; Sanofi; Synthekine; Tavotek Biotherapeutics; and Teva Pharmaceuticals USA, Inc.Grant/Research Support from AstraZeneca; BioNTech SE; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Lessons in Orthopaedic Leadership: An AOA Podcast
Diversity and Unification - A Discussion with Canadian Orthopaedic Association (COA) Past President, Laurie Hiemstra, MD, PhD, FRCSC

Lessons in Orthopaedic Leadership: An AOA Podcast

Play Episode Listen Later Nov 10, 2023 21:59


AOA President Ann Van Heest, MD, FAOA, connected with Canadian Orthopaedic Association (COA) Past President, Laurie Hiemstra, MD, PhD, FRCSC, to discuss her unusual path to leadership, her plan for improving diversity in orthopaedics, and the most pressing critical issues affecting the COA. While waitlisting and licensure issues between provinces continue to be a challenge within the orthopaedic specialty, Dr. Hiemstra made it her goal to advocate for underrepresented groups, unify the community, and help develop competent young orthopaedic leaders. 

Urology Care Podcast
From Healing to Hope: Urologists Share Their Passion for Changing Lives Around the World

Urology Care Podcast

Play Episode Listen Later Nov 9, 2023 10:44


In this episode, we have two of the Urology Care Foundation's Humanitarian Grant Program Recipients with us to talk about their passion for helping bring care to others. The work these doctors do across the world helps the lives of patients and their families. Listen along as Rajiv K. Singal, MD, FRCSC and Dana Weiss, MD share their stories. For more information about Humanitarians in Urology, check out our website here: https://www.urologyhealth.org/humanitarianism/humanitarians-in-urology. For more information about urology, please visit www.urologyhealth.org/ and don't forget to subscribe to our free digital magazine, UrologyHealth extra at https://www.urologyhealth.org/healthy-living/urologyhealth-extra. **** November 9, 2023

JHLT: The Podcast
Episode 36: November 2023

JHLT: The Podcast

Play Episode Listen Later Nov 1, 2023 19:13


It's pulmonary hypertension month on JHLT: The Podcast! The JHLT Digital Media Editors explore two PVD-related manuscripts from the November issue of The Journal of Heart and Lung Transplantation. Digital Media Editor Marty Tam, MD, assistant professor in the division of cardiovascular medicine at the University of Michigan, hosts this episode.   First, hear from first author Zvonimir Rako, MD, on his team's study “Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension.”   The right ventricle (RV) has a complex contraction pattern. For patients with pulmonary hypertension (PH), right ventricular to pulmonary artery (RV-PA) coupling is important when considering how the RV responds to increases in afterload. Uncoupling occurs with progressive disease and the degree of uncoupling can be derived from pressure–volume loop analysis as the ratio between end-systolic and arterial elastance (Ees/Ea).   In this exploratory analysis of the prospective EXERTION study, the authors determined the relationship between RV contraction patterns and RV-PA coupling in patients with PH. They also correlated RV contraction patterns to hemodynamic risk profiles. For details on what the study found about how PH programs can use the results in their practice, listen to the discussion in the episode.   Next, the editors explored the study “Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.” The podcast hosted first author Justin C.Y. Chan, MD, MPhil and senior author Marc de Perrot,  MD, MSc, FRCSC.   The impact of sex on long-term outcomes after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension (CTEPH) has remained unclear. The authors of this study sought to evaluate the early and long-term outcomes after pulmonary endarterectomy to see if sex had an impact on the risk of residual pulmonary hypertension and need for targeted PH medical therapy.    For details on what this retrospective single-center study found, including the mechanics of sex differences and the potential changes to clinical approach, check out the episode.   Follow along at www.jhltonline.org/current, or, if you're an ISHLT member, log in at ishlt.org/journal-of-heart-lung-transplantation.  Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

SurgOnc Today
Peritoneal Mesothelioma – Therapy in 2023 and Beyond

SurgOnc Today

Play Episode Listen Later Aug 25, 2023 9:22


This session will review state of the art therapy for peritoneal mesothelioma. The discussion includes cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as well as systemic chemotherapy and immunotherapy. Edward Levine, MD, moderates this podcast and is Professor of Surgery and Chief, Surgical Oncology at Wake Forest University. Trang Nguyen, MD, is an Assistant Professor of Surgery at Indiana University and Sinziana Dumitra, MD, MSc, FRCSC, FSSO, is an Assistant Professor of Surgery at McGill University. 

The OJSM Hot Corner
2023 OJSM William A. Grana Award Winner - “Effect of Osteochondroplasty on Time to Reoperation After Arthroscopic Management of Femoroacetabular Impingement: Analysis of a Randomized Controlled Trial” with author Dr. Olufemi Ayeni, MD, PhD, FRCSC

The OJSM Hot Corner

Play Episode Listen Later Aug 16, 2023 19:12


2023 OJSM William A. Grana Award for Best Research Paper spotlight - Dr. Olufemi Ayeni from McMaster University Medical Centre in Ontario joins us to discuss his award-winning study “Effect of Osteochondroplasty on Time to Reoperation After Arthroscopic Management of Femoroacetabular Impingement: Analysis of a Randomized Controlled Trial." As hip arthroscopy continues to grow as a beneficial treatment option in Sports Medicine, high level evidence is needed to support its efficacy.  Dr. Ayeni and his group provide high quality data supporting the long term benefits of osteochondroplasty versus soft tissue work alone.

Weight and Healthcare
Weight Loss Surgery and Kids Part 1

Weight and Healthcare

Play Episode Listen Later Jul 29, 2023 14:49


This series is part of the work I'm doing with Weight Inclusive Nutrition and Dietetics (WIND) to create a comprehensive response to the disastrous American Academy of Pediatrics (AAP) guidelines for higher-weight children. I'm part of the team that is analyzing the research that, the AAP claims, supports their recommendations, and I'll be publishing my breakdowns here as well.Today's study is Laparoscopic sleeve gastrectomy in children younger than 14 years: refuting the concernsAayed Alqahtani, MD, FRCSC, FACS, Mohamed Elahmedi, MBBS, and Awadh R. Al Qahtani, MD, MSc, FRCSC Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

iCritical Care: All Audio
SCCM Pod-485: Better Together: The Power of Collaboration

iCritical Care: All Audio

Play Episode Listen Later Jul 20, 2023 27:15


The power of scientific collaboration has a broad reach. During the COVID-19 pandemic, more than 7000 clinical trials were registered, with more than 100 different countries represented. Samantha Gambles Farr, MSN, NP-C, CCRN, RNFA, was joined by SCCM Lifetime Achievement Award Recipient John C. Marshall, MD, FRCSC, FACS, at the 2023 Critical Care Congress to discuss the importance of research and scientific collaboration. Dr. Marshall has been involved in research programs with researchers around the globe and is a well-known speaker with nearly 600 published manuscripts. This podcast is sponsored by Dompe Pharmaceutical.

LIMITLESS Leaders Podcast
Episode 8: Playing Well With the Boys

LIMITLESS Leaders Podcast

Play Episode Listen Later Jul 14, 2023 47:26


Playing Well with the Boys Hosted by Ashley Amalfi, MD, with Guest Speakers Michael Neumeister MD, FRCSC, FACS and Paul Cederna, MD.                                                                                            LIMITLESS Leaders Podcast is made Possible with the support of  Allergan Aesthetics

SurgOnc Today
Nuts and Bolts of Neoadjuvant Therapy for Pancreatic Adenocarcinoma

SurgOnc Today

Play Episode Listen Later Jun 30, 2023 28:19


In this episode of SurgOnc Today, Alexander Parikh MD, MPH, FACS, FSSO, from the University of Texas, San Antonio and Chair of the SSO HPB Disease Site Work Group, and Julie Hallet, MD, M.Sc., FRCSC, from the University of Toronto, and Vice-Chair of the SSO HPB Disease Site Work Group, are joined by Flavio G. Rocha, MD, FACS, FSSO, from the Oregon Health and Science University and Susanne G. Warner, MD, from the Mayo Clinic Rochester. They discuss two important aspects of delivering neoadjuvant therapy for pancreatic adenocarcinoma: the use of staging laparoscopy and the assessment of response. 

The OJSM Hot Corner
“Assessment of 30 Years of Randomized Controlled Trials in The American Journal of Sports Medicine: 1990-2020” with author Dr. Daniel Whelan, MD, MSc, FRCSC

The OJSM Hot Corner

Play Episode Listen Later Jun 21, 2023 20:17


We welcome Dr. Daniel Whelan, Head of University of Toronto Sports Medicine, to discuss his team's recent publication “Assessment of 30 Years of Randomized Controlled Trials in The American Journal of Sports Medicine: 1990-2020.” This critical look at how our very best clinical studies have changed over a 30-year period is a fascinating reflection of our own evolution as orthopaedic sports medicine specialists. The past informs the present and can teach us lessons on how to be better in the future. 

GT: The Podcast
Noninvasive Trabeculotomy Treatment for Glaucoma

GT: The Podcast

Play Episode Listen Later Apr 26, 2023 7:56


Ticiana De Francesco, MD, shares an update on the first-in-human experience with femtosecond laser image-guided high-precision trabeculotomy, or FLIGHT (ViaLase), as covered in an article she coauthored with Iqbal Ike K. Ahmed, MD, FRCSC, for an upcoming issue of Glaucoma Today. Dr. De Francesco describes the new procedure and how it could help expand options for safe and effective glaucoma intervention.

Sickboy
From O.R. Waste to Environmental Grace: The Science of Sustainable Surgery

Sickboy

Play Episode Listen Later Mar 29, 2023 43:07


This week the fellas have the pleasure of speaking with Sean Christie, MD, FRCSC, a renowned neurosurgeon and expert in making operating rooms more environmentally sustainable. Sean is a professor, vice chair, and director of research at the division of neurosurgery at Dalhousie University. Operating rooms are known to generate large amounts of waste and consume significant amounts of energy and resources. Sean shares with us his insights on the importance of creating more eco-conscious operating rooms and the benefits it can bring not only to the environment but also to patient care and hospital finances. Through his expertise and experience, Sean demonstrates how making operating rooms more eco-friendly can have a significant impact on reducing the healthcare industry's environmental footprint and promoting a healthier and more sustainable future for all. Join the post-episode conversation over on Discord! https://discord.gg/expeUDN